CRISM Therapeutics Corporation
Develops implantable tech for localized chemotherapy delivery directly into solid tumors.
CRTX | US
Overview
Corporate Details
- ISIN(s):
- VGG042401262
- LEI:
- 213800XFW6MKVCHHPW88
- Country:
- Virgin Islands (British)
- Address:
- C/O MAPLES FINANCE BVI LIMITED, VG1110 ROAD TOWN
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
CRISM Therapeutics Corporation is a clinical-stage biotechnology company that develops innovative drug delivery technologies to improve cancer treatments. The company's core product is ChemoSeed®, an implantable, biodegradable technology for the sustained and localized delivery of chemotherapy drugs directly into solid tumors. This targeted approach aims to enhance the clinical performance of cancer therapies by increasing drug concentration at the tumor site, thereby improving treatment efficacy while reducing systemic toxicity and associated side effects. CRISM's mission is to provide more efficient, cost-effective, and better-tolerated treatments to improve the quality of life for cancer patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-27 08:25 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.3 KB | ||
| 2025-10-30 08:00 |
Regulatory Filings
US Orphan Drug Designation Application
|
English | 16.0 KB | ||
| 2025-10-14 08:00 |
Regulatory Filings
Positive Preclinical Data in Prostate Cancer
|
English | 17.8 KB | ||
| 2025-09-15 08:00 |
Interim / Quarterly Report
Half Year Report
|
English | 267.8 KB | ||
| 2025-08-26 17:03 |
AGM Information
Result of AGM
|
English | 25.8 KB | ||
| 2025-08-26 08:00 |
AGM Information
AGM Statement
|
English | 15.6 KB | ||
| 2025-08-12 08:00 |
Regulatory Filings
GMP Manufacture of ChemoSeed
|
English | 16.9 KB | ||
| 2025-07-10 16:04 |
Major Shareholding Notification
Holding(s) in Company
|
English | 23.3 KB | ||
| 2025-07-03 08:00 |
Share Issue/Capital Change
Result of Retail Offer and Additional Placing
|
English | 16.8 KB | ||
| 2025-07-01 17:41 |
Capital/Financing Update
Update presentation on the IMC platform
|
English | 14.9 KB | ||
| 2025-06-30 08:01 |
Share Issue/Capital Change
Retail Offer
|
English | 39.0 KB | ||
| 2025-06-30 08:00 |
Share Issue/Capital Change
Placing
|
English | 58.0 KB | ||
| 2025-03-31 08:00 |
Legal Proceedings Report
Clinical Trial Update
|
English | 17.3 KB | ||
| 2025-03-27 08:00 |
Regulatory Filings
Innovate UK Grant Award
|
English | 20.3 KB |
Automate Your Workflow. Get a real-time feed of all CRISM Therapeutics Corporation filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CRISM Therapeutics Corporation
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CRISM Therapeutics Corporation via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
